Dominican Republic
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Dominican Republic (DO)
| 2000 | 255.0 thousand |
| 2011 | 431.6 thousand |
| 2024 | 1.2 million |
| 2050 | 1.8 million |
Dominican Republic is one of the 19 countries and territories in the IDF South and Central America Region. Dominican Republic has the highest diabetes prevalence (20-79 years) in the Region.
Data source(s) used for the diabetes estimates in adults:
- Ministry of Health Dominican Republic. National Health Survey República Dominicana, 2007.
- Peguero P.M., Collado D., Warden F., Almonte C., Suero M., REVISTA ARCHIVOS DOMINICANOS DE CARDIOLOGÍA.2012.
- Valery E Madsen Beau De Rochars et al. Am J Trop Med Hyg
. 2021 Jun 2;104(6):2241-2250. doi: 10.4269/ajtmh.19-0942. PMID:33872205
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 255.0 | 431.6 | 1,203.7 | 1,817.4 |
| Age-standardised prevalence of diabetes, % | - | 8.1 | 17.6 | 19.9 |
| Proportion of people with undiagnosed diabetes, % | - | - | 42.8 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 514.9 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 666.7 | 959.8 |
| Age-standardised prevalence of IFG, % | - | - | 9.5 | 10.5 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 326.0 | 769.7 | 1,120.1 |
| Age-standardised prevalence of IGT, % | - | 5.9 | 11.1 | 12.2 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 5,450.0 | 7,156.8 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 15.2 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 1,629.7 | 2,039.6 |
| Total diabetes-related health expenditure, ID million | - | - | 3,592.7 | 4,496.5 |
| Diabetes-related health expenditure per person, USD | - | 414.0 | 1,353.9 | 1,122.3 |
| Diabetes-related health expenditure per person, ID | - | - | 2,984.7 | 2,474.1 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 6,506.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 1,441.0 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 4,797.0 | 5,846.8 | 7,255.5 | 9,180.2 |
| Population of children and adolescents (0-19 y) | - | - | 4,010,313.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 255.0 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 4,797.0 |
| Population of children and adolescents (0-19 y) | - |
